Methylene Blue

CHEMBL550495 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
319.9 g/mol
LogP
Phase
4

A medication with multiple uses, including treatment of methemoglobinemia (a condition where blood cannot carry enough oxygen) and as a dye for surgical mapping. It is also used at low doses as an adjunct for certain types of depression and is being studied for neurodegenerative diseases.

Moleküler Ağırlık

319,9000 g/mol

TPSA

43,90 Ų

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1.O.O.O.[Cl-]

InChI

InChI=1S/C16H18N3S.ClH.3H2O/c1-18(2)11-5-7-13-15(9-11)20-16-10-12(19(3)4)6-8-14(16)17-13;;;;/h5-10H,1-4H3;1H;3*1H2/q+1;;;;/p-1

Molecular Formula

C16H18ClN3S

HBD / HBA

- / 4

Döndürülebilir Bağlar

1

Ağır Atomlar

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A medication with multiple uses, including treatment of methemoglobinemia (a condition where blood cannot carry enough oxygen) and as a dye for surgical mapping. It is also used at low doses as an adjunct for certain types of depression and is being studied for neurodegenerative diseases.

Yes, Methylene Blue is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL550495. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6099. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.